FR2631239B1 - Anticorps monoclonal humain et hybridome le produisant - Google Patents

Anticorps monoclonal humain et hybridome le produisant

Info

Publication number
FR2631239B1
FR2631239B1 FR8906125A FR8906125A FR2631239B1 FR 2631239 B1 FR2631239 B1 FR 2631239B1 FR 8906125 A FR8906125 A FR 8906125A FR 8906125 A FR8906125 A FR 8906125A FR 2631239 B1 FR2631239 B1 FR 2631239B1
Authority
FR
France
Prior art keywords
same
monoclonal antibodies
human monoclonal
hybridoma producing
hybridoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8906125A
Other languages
English (en)
French (fr)
Other versions
FR2631239A1 (fr
Inventor
Shinichi Yokota
Hiroshi Ohtsuka
Hiroshi Ochi
Hiroshi Noguchi
Masazumi Terashima
Masuhiro Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd, Sumitomo Chemical Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of FR2631239A1 publication Critical patent/FR2631239A1/fr
Application granted granted Critical
Publication of FR2631239B1 publication Critical patent/FR2631239B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR8906125A 1988-05-10 1989-05-10 Anticorps monoclonal humain et hybridome le produisant Expired - Fee Related FR2631239B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11447388 1988-05-10

Publications (2)

Publication Number Publication Date
FR2631239A1 FR2631239A1 (fr) 1989-11-17
FR2631239B1 true FR2631239B1 (fr) 1994-05-27

Family

ID=14638614

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8906125A Expired - Fee Related FR2631239B1 (fr) 1988-05-10 1989-05-10 Anticorps monoclonal humain et hybridome le produisant

Country Status (10)

Country Link
US (1) US5252480A (Direct)
EP (1) EP0341684B1 (Direct)
JP (1) JP2645665B2 (Direct)
AT (1) AT397803B (Direct)
BE (1) BE1001964A4 (Direct)
CH (1) CH681012A5 (Direct)
DE (1) DE68920624T2 (Direct)
FR (1) FR2631239B1 (Direct)
GB (1) GB2218703B (Direct)
IT (1) IT1232273B (Direct)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
JPH04211393A (ja) * 1990-02-08 1992-08-03 Sumitomo Pharmaceut Co Ltd ヒトモノクローナル抗体及びそれを有効成分とする緑膿菌感染症治療剤
GB9105292D0 (en) * 1991-03-13 1991-04-24 Sandoz Ltd Improvements in or relating to organic compounds
US5648660A (en) * 1996-01-05 1997-07-15 Sterling Diagnostic Imaging, Inc. Method and apparatus for reducing noise in a radiation capture device
US6197582B1 (en) 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
EP2311490A3 (en) 1998-07-13 2011-05-04 Board of Regents, The University of Texas System Uses of antibodies to aminophospholipids for cancer treatment
US7060802B1 (en) * 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
DE60139944D1 (de) * 2000-10-12 2009-10-29 Genentech Inc Niederviskose konzentrierte proteinformulierungen
AU2003293543A1 (en) * 2002-12-13 2004-07-09 Abgenix, Inc. System and method for stabilizing antibodies with histidine
US20050158303A1 (en) * 2003-04-04 2005-07-21 Genentech, Inc. Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
PL1610820T5 (pl) * 2003-04-04 2014-01-31 Genentech Inc Preparaty zawierające wysokoskoncentrowane przeciwciała i białka
FR2859725B1 (fr) * 2003-09-16 2006-03-10 Neovacs Procede a haut rendement pour l'obtention d'anticorps humains neutralisant l'activite biologique d'une cytokine humaine
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
SG174258A1 (en) * 2009-03-06 2011-10-28 Genentech Inc Antibody formulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151128B1 (en) * 1983-05-06 1991-07-03 Velos Group Monoclonal antibodies reactive with endotoxin core
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
AU584690B2 (en) * 1985-03-11 1989-06-01 Teijin Limited E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
JPS62215131A (ja) * 1986-03-13 1987-09-21 Kawasaki Heavy Ind Ltd 遠心クラツチ
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
AU1807188A (en) * 1987-04-10 1988-11-04 Xoma Corporation Human monoclonal antibodies binding determinants of gram negative bacteria

Also Published As

Publication number Publication date
DE68920624D1 (de) 1995-03-02
CH681012A5 (Direct) 1992-12-31
JPH0284197A (ja) 1990-03-26
EP0341684B1 (en) 1995-01-18
IT1232273B (it) 1992-01-28
AT397803B (de) 1994-07-25
IT8967343A0 (it) 1989-05-09
EP0341684A2 (en) 1989-11-15
GB8910395D0 (en) 1989-06-21
DE68920624T2 (de) 1995-07-27
FR2631239A1 (fr) 1989-11-17
JP2645665B2 (ja) 1997-08-25
ATA111789A (de) 1993-11-15
BE1001964A4 (fr) 1990-04-24
GB2218703B (en) 1992-10-28
GB2218703A (en) 1989-11-22
EP0341684A3 (en) 1990-01-17
US5252480A (en) 1993-10-12

Similar Documents

Publication Publication Date Title
DK666389D0 (da) Monoklonalt antistof
IL88145A0 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
FI925631A7 (fi) Monoklonaaliset vasta-aineet
FR2631239B1 (fr) Anticorps monoclonal humain et hybridome le produisant
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
FI940811L (fi) Ihmisen monoklonaalisia anti-Rhesus(D) -vasta-aineita ja niitä tuottavat solulinjat
DK190889A (da) Antigen
EP0285511A3 (en) Monoclonal antibodies and their uses
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
DK69690A (da) Humane anti-rh(d) monoklonale antistoffer
DK717888A (da) Monoklonale antistoffer
DK69590D0 (da) Humane anti-rh(d) monoklonale antistoffer
NO890116D0 (no) Monoklonale antistoffer.
EP0229107A4 (en) PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO -i(PSEUDOMONAS AERUGINOSA) EXOTOXIN A.
FI945485L (fi) Monoklonaaliset vasta-aineet ja niiden käyttö
FI894551A7 (fi) Hybridiset monoklonaaliset vasta-aineet, niiden valmistus ja käyttö
GB8901832D0 (en) Human monoclonal antibody and its production and use
DE3687542D1 (de) Monoklonaler antikoerper gegen humanes protein c.
FI895829A7 (fi) Ihmisen monoklonaaliset vasta-aineet rabiesvirusta vastaan
DK370089A (da) Anti-urokinase monoklonale antistoffer
DK413389D0 (da) Monoklonale antistoffer
GB8830115D0 (en) Monoclonal antibody and preparation and use thereof
FR2692786B1 (fr) Anticorps monoclonaux humains anti-rhesus d et lignees cellulaires les produisant.
DK220688D0 (da) Monoklonalt antistof
ATE99332T1 (de) Monoklonale antikoerper gegen menschliche interleukin-4 und die sie erzeugenden hybridomen.

Legal Events

Date Code Title Description
ST Notification of lapse